Developer docs
API playgroundTry for free, no card

Search company profiles

DRNEXT LTD

Full company profile

uuid025q2o4

Namestring
DRNEXT LTD
Legal namestring
DrNext Inc.
Websiteurl
drnext.co.uk
Company typeenum
Private
Founded yearint
2021
Descriptiontext

DRNEXT LTD operates a modular AI-powered digital health platform that delivers AI symptom triage, virtual GP consultations, AI-driven cancer risk detection, and computational psychiatry-based mental health support. The company was founded in 2021 by Dr. Saeid Taheri as DrNext.ir in Iran, where the platform has recorded 70 million+ visits, served 12 million+ patients, and is used by 15,000+ physicians. The UK expansion under DrNext.co.uk launched in 2024 and is supported by DrNext Ltd. (UK private limited company) and DrNext Inc. (USA). Ownership is founder-dominant, with no disclosed institutional funding rounds and family investor involvement through Abdolkarim Taheri (Investor & Head of Finance); a wholly-owned subsidiary, PsychoNext, houses the mental health product line.

The platform's technology stack combines probabilistic reasoning engines, neural networks, Bayesian inference, reinforcement learning, and large language model-guided generative AI, with proprietary training data comprising 50 million+ patient records for the symptom checker and 1M+ labeled cancer cases for the risk detection model. Four core products — AI Symptom Checker, Virtual GP, AI Cancer Risk Detection, and the Mental Health Solution (PsychoNext) — are designed to interoperate with NHS referral workflows including 2WW cancer pathways and ICS structures, integrating EHR and electronic referral tools.

Revenue is generated via subscription/recurring licensing of AI modules to NHS organisations (ICSs, PCNs, GP practices) and private health insurers, alongside direct-to-patient services. The go-to-market is sales-led and consultative, with quote-based enterprise pricing and no publicly disclosed price tiers, ARR, or revenue figures. Marketing emphasis is on thought-leadership content addressing specific NHS care gaps (GP access waits, cancer referral delays, mental health service dissatisfaction). The company has not disclosed certifications, regulatory clearances, named enterprise customers, or completed funding rounds in the source material.

Short descriptiontext

DRNEXT LTD operates a modular AI-powered digital health platform offering AI symptom triage, cancer risk detection, mental health support, and virtual GP consultations, targeting NHS organisations, private health insurers, and individual patients in the UK and Iran.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
AI symptom triage, virtual GP consultations, cancer risk detection, computational psychiatry, digital health platform
Industry6 codes
PRIMARYHLALAJAM
Integrated Virtual-First Primary + Urgent Hybrid Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms
SECONDARYHLALAAAA
Primary Care & General Medicine Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLALACAA
General Medical Virtual Primary Care (Payer-Branded)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALADAJ
Care Navigation, Advocacy & Benefits Guidance Platforms
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms
NAICS code1 code
  • Offices of Physicians, Mental Health Specialists621112
SIC code2 codes
  • Services-Health Services8000
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Digital Health Platform
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1NHS/Healthcare System Licensing
TypeSubscription Recurring
Description

Licensing of AI modules to NHS organisations (ICSs, PCNs, GP practices) for AI triage, early cancer detection, and mental health assessments. Supports Long Term Plan goals with digital-first care solutions.

drnext.co.uk
2Private Health Insurer Licensing
TypeSubscription Recurring
Description

Licensing AI modules to private health insurers to reduce claims, enhance early intervention, and provide high-value digital health tools to members.

drnext.co.uk
3Direct-to-Patient Services
TypeSubscription Recurring
Description

Patient-facing platform offering AI-powered symptom checking, virtual GP visits, and mental health tools for individuals seeking faster access to care, particularly those facing NHS delays.

drnext.co.uk
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 record
1PsychoNext
Description

Mental health solution featuring gamified computational psychiatry tasks and AI-guided intake using LLMs, led by Dr. Sharareh Abdallah Khani as Co-Founder and Head of Mental Health Solution.

drnext.co.uk
Core offering1 text field

DrNext provides an AI-powered digital health platform comprising four modular products: an AI Symptom Checker for intelligent triage trained on 50 million patient records; a Virtual GP platform offering same-day video consultations with integrated EHR and referral tools; an AI Cancer Risk Detection system using machine learning to predict high-risk patients without imaging; and a Mental Health Solution combining gamified computational psychiatry with LLM-guided intake. The platform is licensed to NHS organisations and private health insurers and is also accessible directly to individual patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduces unnecessary GP appointments through AI-powered pre-triage
+3 more records
Product overview1 text field

DrNext provides a scalable, modular digital health platform that combines four core AI-powered products: AI Symptom Checker for intelligent triage, Virtual GP for video consultations, AI Cancer Risk Detection for predictive cancer screening, and Mental Health Solution for computational psychiatry-based mental health support. The platform is designed to address NHS service gaps by enabling earlier detection, faster triage, and personalized digital care, with components that integrate into unified patient pathways from initial symptom assessment through specialist referral.

Product and service4 records
1AI Symptom Checker
CategoryAI Symptom Triage
Description

AI-powered digital triage tool trained on 50 million patient records that uses a probabilistic reasoning engine and neural networks to dynamically assess symptoms, estimate diagnosis likelihood via Bayesian inference, and direct patients to appropriate care pathways (self-care, pharmacy, virtual GP, or secondary care). Designed for NHS organisations, private health insurers, and individual patients.

2Virtual GP
CategoryTelemedicine / Virtual Consultations
Description

Secure, high-quality video consultation platform providing same-day or next-day GP appointments. Presents clinicians with pre-collected structured data, clinical summaries, flagged red-flag symptoms, and ranked potential diagnoses, with integrated EHR and electronic referral tools to reduce administrative burden. Targeted at NHS GP practices, private health insurers, and individual patients.

3AI Cancer Risk Detection
CategoryAI Diagnostics / Predictive Risk
Description

Machine learning system trained on over one million categorised cancer patient records that predicts high-risk patients from self-reported symptoms and health data without requiring imaging. Includes algorithmic prioritisation, urgency scoring, automated referral pathways, and integration with NHS workflows such as 2WW and ICS pathways. Targeted at NHS organisations, private health insurers, and clinicians.

4Mental Health Solution
CategoryDigital Mental Health
Description

Digital mental health platform combining gamified computational psychiatry tasks (trust games, decision-making challenges, emotion-processing exercises) with generative AI-guided intake using LLMs. Applies reinforcement learning and Bayesian inference for personalised cognitive profiling and provides bridging care for patients awaiting formal mental health treatment. Delivered through subsidiary PsychoNext. Targeted at NHS mental health services, private health insurers, and individual patients.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Original digital health platform in Iran serving 15M+ patients, 70M+ visits, and 15,000+ physicians. Provides proven infrastructure, data assets, and operational experience that underpins the UK expansion. Shares founder Dr. Saeid Taheri and core technology platform.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

UK-based AI dermatology platform using machine learning for skin cancer detection and NHS pathway integration — comparable to DrNext's AI Cancer Risk Detection in AI-driven oncology and NHS integration approach.

2Babylon Health
TypeDirect peer
Description

UK-based digital health platform offering AI symptom triage and virtual GP consultations to NHS organisations and patients — directly comparable in product mix (AI triage + virtual GP), NHS target customer, and B2B/B2C hybrid model.

TypeDirect peer
Description

UK-based digital GP service providing video consultations to NHS patients and private users — closely comparable to DrNext's Virtual GP product in customer segment, delivery mechanism, and UK NHS focus.

TypeEmerging player
Description

AI medical imaging company focused on cancer detection (notably breast cancer screening) — comparable to DrNext's AI Cancer Risk Detection in AI-driven oncology positioning, though Kheiron's modality is imaging rather than symptom-based.

TypeEmerging player
Description

UK virtual ward and remote patient monitoring platform working with NHS trusts — partially comparable to DrNext in NHS-focused digital health delivery and chronic/acute care pathway integration.

TypeEmerging player
Description

UK AI platform for early cancer detection using symptom-based risk assessment integrated with NHS pathways — directly comparable to DrNext's AI Cancer Risk Detection in symptom-based cancer prediction and NHS 2WW integration.

TypeBroad incumbent
Description

Global telehealth incumbent offering virtual care, AI triage, and chronic condition management across multiple geographies — a broad incumbent with overlapping virtual primary care and AI capabilities relevant to DrNext's product portfolio.

TypeEmerging player
Description

UK AI mental health platform using machine learning to improve access to psychological therapies and integrate with NHS IAPT pathways — comparable to DrNext's Mental Health Solution in AI-driven mental health and NHS targeting.

TypeDirect peer
Description

AI-powered symptom assessment platform serving consumers, health systems, and insurers globally — directly comparable to DrNext's AI Symptom Checker in core functionality, probabilistic reasoning approach, and enterprise health system partnerships.

TypeDirect peer
Description

European digital GP platform providing video consultations and AI-assisted triage across the UK and Nordics — comparable to DrNext's Virtual GP and AI Symptom Checker offering and similar NHS/private-pay hybrid GTM.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DRNEXT LTD

Digital Health Platformdrnext.co.uk

DRNEXT LTD operates a modular AI-powered digital health platform offering AI symptom triage, cancer risk detection, mental health support, and virtual GP consultations, targeting NHS organisations, private health insurers, and individual patients in the UK and Iran.

What DRNEXT LTD does

DRNEXT LTD operates a modular AI-powered digital health platform that delivers AI symptom triage, virtual GP consultations, AI-driven cancer risk detection, and computational psychiatry-based mental health support. The company was founded in 2021 by Dr. Saeid Taheri as DrNext.ir in Iran, where the platform has recorded 70 million+ visits, served 12 million+ patients, and is used by 15,000+ physicians. The UK expansion under DrNext.co.uk launched in 2024 and is supported by DrNext Ltd. (UK private limited company) and DrNext Inc. (USA). Ownership is founder-dominant, with no disclosed institutional funding rounds and family investor involvement through Abdolkarim Taheri (Investor & Head of Finance); a wholly-owned subsidiary, PsychoNext, houses the mental health product line.

The platform's technology stack combines probabilistic reasoning engines, neural networks, Bayesian inference, reinforcement learning, and large language model-guided generative AI, with proprietary training data comprising 50 million+ patient records for the symptom checker and 1M+ labeled cancer cases for the risk detection model. Four core products — AI Symptom Checker, Virtual GP, AI Cancer Risk Detection, and the Mental Health Solution (PsychoNext) — are designed to interoperate with NHS referral workflows including 2WW cancer pathways and ICS structures, integrating EHR and electronic referral tools.

Revenue is generated via subscription/recurring licensing of AI modules to NHS organisations (ICSs, PCNs, GP practices) and private health insurers, alongside direct-to-patient services. The go-to-market is sales-led and consultative, with quote-based enterprise pricing and no publicly disclosed price tiers, ARR, or revenue figures. Marketing emphasis is on thought-leadership content addressing specific NHS care gaps (GP access waits, cancer referral delays, mental health service dissatisfaction). The company has not disclosed certifications, regulatory clearances, named enterprise customers, or completed funding rounds in the source material.

DRNEXT LTD firmographics

Firmographics
Name
DRNEXT LTD
Legal name
DrNext Inc.
Website
https://drnext.co.uk
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
DRNEXT LTD operates a modular AI-powered digital health platform offering AI symptom triage, cancer risk detection, mental health support, and virtual GP consultations, targeting NHS organisations, private health insurers, and individual patients in the UK and Iran.
Ownership category
akta.pro rank

DRNEXT LTD industry classification

Industry
Product category
Digital Health Platform
NAICS
Offices of Physicians, Mental Health Specialists (621112)
SIC
Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLALAJAM
Integrated Virtual-First Primary + Urgent Hybrid Platforms
Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms
SECONDARYHLALAAAA
Primary Care & General Medicine Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAEAB
Psychiatry & Medication Management Platforms
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLALACAA
General Medical Virtual Primary Care (Payer-Branded)
Healthcare & Life Sciences/Telehealth Platforms/Payer-Sponsored Virtual Care Platforms
SECONDARYHLALADAJ
Care Navigation, Advocacy & Benefits Guidance Platforms
Healthcare & Life Sciences/Telehealth Platforms/Employer-Sponsored Virtual Care Platforms

Keywords

  • AI symptom triage
  • Virtual GP consultations
  • Cancer risk detection
  • Computational psychiatry
  • Digital health platform

Where DRNEXT LTD is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

DRNEXT LTD business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. NHS/Healthcare System Licensing: Licensing of AI modules to NHS organisations (ICSs, PCNs, GP practices) for AI triage, early cancer detection, and mental health assessments. Supports Long Term Plan goals with digital-first care solutions.
  2. Private Health Insurer Licensing: Licensing AI modules to private health insurers to reduce claims, enhance early intervention, and provide high-value digital health tools to members.
  3. Direct-to-Patient Services: Patient-facing platform offering AI-powered symptom checking, virtual GP visits, and mental health tools for individuals seeking faster access to care, particularly those facing NHS delays.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

DRNEXT LTD product offering

Product offering

Core offering

DrNext provides an AI-powered digital health platform comprising four modular products: an AI Symptom Checker for intelligent triage trained on 50 million patient records; a Virtual GP platform offering same-day video consultations with integrated EHR and referral tools; an AI Cancer Risk Detection system using machine learning to predict high-risk patients without imaging; and a Mental Health Solution combining gamified computational psychiatry with LLM-guided intake. The platform is licensed to NHS organisations and private health insurers and is also accessible directly to individual patients.

Product overview

DrNext provides a scalable, modular digital health platform that combines four core AI-powered products: AI Symptom Checker for intelligent triage, Virtual GP for video consultations, AI Cancer Risk Detection for predictive cancer screening, and Mental Health Solution for computational psychiatry-based mental health support. The platform is designed to address NHS service gaps by enabling earlier detection, faster triage, and personalized digital care, with components that integrate into unified patient pathways from initial symptom assessment through specialist referral.

Differentiator

Problem solved

Functional benefit

Brands

  • PsychoNext: Mental health solution featuring gamified computational psychiatry tasks and AI-guided intake using LLMs, led by Dr. Sharareh Abdallah Khani as Co-Founder and Head of Mental Health Solution.

Products and services

  • AI Symptom Checker AI-powered digital triage tool trained on 50 million patient records that uses a probabilistic reasoning engine and neural networks to dynamically assess symptoms, estimate diagnosis likelihood via Bayesian inference, and direct patients to appropriate care pathways (self-care, pharmacy, virtual GP, or secondary care). Designed for NHS organisations, private health insurers, and individual patients.
  • Virtual GP Secure, high-quality video consultation platform providing same-day or next-day GP appointments. Presents clinicians with pre-collected structured data, clinical summaries, flagged red-flag symptoms, and ranked potential diagnoses, with integrated EHR and electronic referral tools to reduce administrative burden. Targeted at NHS GP practices, private health insurers, and individual patients.
  • AI Cancer Risk Detection Machine learning system trained on over one million categorised cancer patient records that predicts high-risk patients from self-reported symptoms and health data without requiring imaging. Includes algorithmic prioritisation, urgency scoring, automated referral pathways, and integration with NHS workflows such as 2WW and ICS pathways. Targeted at NHS organisations, private health insurers, and clinicians.
  • Mental Health Solution Digital mental health platform combining gamified computational psychiatry tasks (trust games, decision-making challenges, emotion-processing exercises) with generative AI-guided intake using LLMs. Applies reinforcement learning and Bayesian inference for personalised cognitive profiling and provides bridging care for patients awaiting formal mental health treatment. Delivered through subsidiary PsychoNext. Targeted at NHS mental health services, private health insurers, and individual patients.

Quantifiable outcome

  • Reduces unnecessary GP appointments through AI-powered pre-triage
  • +3 more outcomes

Companies that use DRNEXT LTD

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

DRNEXT LTD technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

DRNEXT LTD partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • DrNext.ir (Iran Operations)coreStrategic or Co-development PartnerOriginal digital health platform in Iran serving 15M+ patients, 70M+ visits, and 15,000+ physicians. Provides proven infrastructure, data assets, and operational experience that underpins the UK expansion. Shares founder Dr. Saeid Taheri and core technology platform.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

DRNEXT LTD competitors and assessment

Company assessment

Emerging players

  • Skin Analytics: UK-based AI dermatology platform using machine learning for skin cancer detection and NHS pathway integration — comparable to DrNext's AI Cancer Risk Detection in AI-driven oncology and NHS integration approach.
  • Kheiron Medical: AI medical imaging company focused on cancer detection (notably breast cancer screening) — comparable to DrNext's AI Cancer Risk Detection in AI-driven oncology positioning, though Kheiron's modality is imaging rather than symptom-based.
  • Doccla: UK virtual ward and remote patient monitoring platform working with NHS trusts — partially comparable to DrNext in NHS-focused digital health delivery and chronic/acute care pathway integration.
  • C the Signs: UK AI platform for early cancer detection using symptom-based risk assessment integrated with NHS pathways — directly comparable to DrNext's AI Cancer Risk Detection in symptom-based cancer prediction and NHS 2WW integration.
  • Limbic: UK AI mental health platform using machine learning to improve access to psychological therapies and integrate with NHS IAPT pathways — comparable to DrNext's Mental Health Solution in AI-driven mental health and NHS targeting.

Direct peers

  • Babylon Health: UK-based digital health platform offering AI symptom triage and virtual GP consultations to NHS organisations and patients — directly comparable in product mix (AI triage + virtual GP), NHS target customer, and B2B/B2C hybrid model.
  • Push Doctor: UK-based digital GP service providing video consultations to NHS patients and private users — closely comparable to DrNext's Virtual GP product in customer segment, delivery mechanism, and UK NHS focus.
  • Ada Health: AI-powered symptom assessment platform serving consumers, health systems, and insurers globally — directly comparable to DrNext's AI Symptom Checker in core functionality, probabilistic reasoning approach, and enterprise health system partnerships.
  • Kry (Livi): European digital GP platform providing video consultations and AI-assisted triage across the UK and Nordics — comparable to DrNext's Virtual GP and AI Symptom Checker offering and similar NHS/private-pay hybrid GTM.

Broad incumbents

  • Teladoc Health: Global telehealth incumbent offering virtual care, AI triage, and chronic condition management across multiple geographies — a broad incumbent with overlapping virtual primary care and AI capabilities relevant to DrNext's product portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

DRNEXT LTD social profiles

Digital presence

DRNEXT LTD financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DRNEXT LTD leadership team

Management profile

Number of profiles

Profiles9 records

DRNEXT LTD subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

DRNEXT LTD funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DRNEXT LTD M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DRNEXT LTD

What does DRNEXT LTD do?

DrNext provides an AI-powered digital health platform comprising four modular products: an AI Symptom Checker for intelligent triage trained on 50 million patient records; a Virtual GP platform offering same-day video consultations with integrated EHR and referral tools; an AI Cancer Risk Detection system using machine learning to predict high-risk patients without imaging; and a Mental Health Solution combining gamified computational psychiatry with LLM-guided intake. The platform is licensed to NHS organisations and private health insurers and is also accessible directly to individual patients.

Is DRNEXT LTD a public or private company?

DRNEXT LTD is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DRNEXT LTD founded?

DRNEXT LTD was founded in 2021. It employs 1 to 10 people.

Where is DRNEXT LTD based?

DRNEXT LTD is headquartered in London, United Kingdom, in the Europe region.

How does DRNEXT LTD make money?

Three revenue lines are on record. NHS/Healthcare System Licensing is the primary driver. The others are private Health Insurer Licensing and direct-to-Patient Services.

Who are DRNEXT LTD's main competitors?

Emerging players on record are Skin Analytics, Kheiron Medical, Doccla, C the Signs and Limbic. Direct peers are Babylon Health, Push Doctor, Ada Health and Kry (Livi). Teladoc Health is listed as a broad incumbent.

Does DRNEXT LTD have an API?

No public API is recorded for DRNEXT LTD.

What industry is DRNEXT LTD in?

DRNEXT LTD's product category is Digital Health Platform. Its primary akta.pro industry code is HLALAJAM, Integrated Virtual-First Primary + Urgent Hybrid Platforms, with a secondary code of HLALAAAA, Primary Care & General Medicine Virtual Care. Its NAICS code is 621112 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales